These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92. Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. Lu G; Sun H; She P; Youn JY; Warburton S; Ping P; Vondriska TM; Cai H; Lynch CJ; Wang Y J Clin Invest; 2009 Jun; 119(6):1678-87. PubMed ID: 19411760 [TBL] [Abstract][Full Text] [Related]
93. Amino acids levels and lipid peroxidation in maple syrup urine disease patients. Barschak AG; Sitta A; Deon M; Busanello EN; Coelho DM; Cipriani F; Dutra-Filho CS; Giugliani R; Wajner M; Vargas CR Clin Biochem; 2009 Apr; 42(6):462-6. PubMed ID: 19121297 [TBL] [Abstract][Full Text] [Related]
94. Oxidative stress in plasma from maple syrup urine disease patients during treatment. Barschak AG; Sitta A; Deon M; Barden AT; Dutra-Filho CS; Wajner M; Vargas CR Metab Brain Dis; 2008 Mar; 23(1):71-80. PubMed ID: 18026828 [TBL] [Abstract][Full Text] [Related]
95. Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease. Barschak AG; Sitta A; Deon M; de Oliveira MH; Haeser A; Dutra-Filho CS; Wajner M; Vargas CR Metab Brain Dis; 2006 Dec; 21(4):279-86. PubMed ID: 17091400 [TBL] [Abstract][Full Text] [Related]
96. Oxidative stress markers in bipolar disorder: a meta-analysis. Andreazza AC; Kauer-Sant'anna M; Frey BN; Bond DJ; Kapczinski F; Young LT; Yatham LN J Affect Disord; 2008 Dec; 111(2-3):135-44. PubMed ID: 18539338 [TBL] [Abstract][Full Text] [Related]
97. Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles. Barschak AG; Marchesan C; Sitta A; Deon M; Giugliani R; Wajner M; Vargas CR Clin Biochem; 2008 Mar; 41(4-5):317-24. PubMed ID: 18088602 [TBL] [Abstract][Full Text] [Related]